Award NoticeAwarded

Clinical Proof of Concept of OVX836, a single-shot broadly protective Influenza A vaccine for immediate protection against emerging pandemic strains

HEALTH AND HUMAN SERVICES, DEPARTMENT OF · ASPR ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE

This notice records an award. Find active opportunities

Award Information

This solicitation resulted in an award to OSIVAX Paris 8 le-de-France 75008 FRA for approximately $98,593,151 on July 25, 2025. Similar contracts are typically issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF under 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Award Number: 75A50125C00008
Award Amount: $98,593,151
Award Date: July 25, 2025
Awardee: OSIVAX Paris 8 le-de-France 75008 FRA

View full award details on USASpending.gov

Contract Details

Notice ID: 75A50125C00008
Opportunity Type: Award Notice
Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-Agency: OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Office: ASPR ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE
Posted Date: Tuesday, October 14, 2025
Response Deadline: Not specified
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC Code: AN11
Set-Aside: No Set Aside
Place of Performance: Paris 8, 75008, FRA
Status: Awarded